Indocollyre

Indometacin, the active ingredient in Indocollyre, is a nonsteroidal anti‑inflammatory drug (NSAID) presented as an ophthalmic solution for ocular use. It reduces inflammation by inhibiting prostaglandin synthesis and is indicated for the treatment of eye inflammation and postoperative ocular inflammation in patients requiring topical anti‑inflammatory therapy.

GNH USA supplies Indocollyre as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU quality standards and provides regulatory documentation to support global distribution. Clients benefit from reliable supply chains and responsive technical support for product integration.

Indometacin ophthalmic solution is used to manage ocular inflammation by targeting prostaglandin‑mediated pathways.

Inflammation of the eye: Reduces swelling, pain and photophobia associated with acute ocular inflammatory conditions. Post‑operative ocular inflammation: Controls postoperative swelling and discomfort to promote healing after eye surgery. Anterior uveitis: Provides anti‑inflammatory effect to alleviate pain and visual disturbance in anterior segment inflammation.

Indometacin eye drops may cause local and systemic adverse reactions.

Common Side Effects: - Burning or stinging sensation upon instillation - Transient blurred vision - Conjunctival hyperemia (redness) - Increased tearing - Mild ocular irritation

Serious or Rare Side Effects: - Corneal ulceration or epithelial defects - Severe allergic reaction (e.g., angio‑edema, anaphylaxis) - Significant rise in intra‑ocular pressure - Persistent ocular pain or vision loss - Systemic NSAID effects such as gastrointestinal bleeding

When prescribing Indocollyre, clinicians should consider several safety measures.

Assess for hypersensitivity: Avoid use in patients with known indometacin or NSAID allergy. Monitor intra‑ocular pressure: Use caution in glaucoma or ocular hypertension patients. Avoid concurrent ocular infection: Do not administer if active bacterial or viral eye infection is present. Limit duration of therapy: Use only for the prescribed period, typically short‑term. Pregnancy and lactation: Safety not established; prescribe only if benefit outweighs potential risk. Store at room temperature: Keep below 25 °C, protect from light and moisture in the original container.

Indometacin eye drops can interact with systemic and ocular agents.

Major Interactions (Avoid): - Systemic NSAIDs: Concurrent use may increase risk of systemic toxicity and renal effects. - Anticoagulants (e.g., warfarin): May enhance bleeding tendency. - Corticosteroid eye drops: Potential for delayed wound healing when used together.

Moderate Interactions (Monitor Closely): - Other ocular medications (e.g., mydriatics): May alter absorption or efficacy. - Beta‑blocker eye drops: Possible additive systemic beta‑blockade. - Topical ocular anesthetics: May increase corneal toxicity risk.